DermTech, Inc. Common Stock
DMTK
DMTK was delisted on the 26th of June, 2024.
134 hedge funds and large institutions have $97.7M invested in DermTech, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 37 increasing their positions, 42 reducing their positions, and 42 closing their positions.
299% more call options, than puts
Call options by funds: $933K | Put options by funds: $234K
12% less funds holding
Funds holding: 152 → 134 (-18)
12% less repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 42
36% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 42
71% less capital invested
Capital invested by funds: $341M → $97.7M (-$243M)
100% less funds holding in top 10
Funds holding in top 10: 4 → 0 (-4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$13.6M |
| 2 |
Millennium Management
New York
|
+$6.64M |
| 3 |
AIA
Avalon Investment & Advisory
Houston,
Texas
|
+$2.25M |
| 4 |
Two Sigma Investments
New York
|
+$2.15M |
| 5 |
LCM
Landscape Capital Management
Englewood,
New Jersey
|
+$1.91M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CC
Casdin Capital
New York
|
-$25.6M |
| 2 |
State Street
Boston,
Massachusetts
|
-$23.7M |
| 3 |
BlackRock
New York
|
-$9.57M |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$8.38M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
-$6.3M |
DMTK Hedge Fund Activity: Q2 2022 in Review
134 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in DermTech, Inc. Common Stock (DMTK) for Q2 2022, worth a combined $97.7M — down 71% from $341M a quarter earlier.
Sellers outnumbered buyers: 42 funds closed out of DMTK and 27 opened new positions — a net loss of 15 holders — while 42 trimmed existing stakes and 37 added.
The largest buyer was UBS O'Connor, adding an estimated $13.6M. The largest seller was Casdin Capital, exiting entirely with an estimated $25.6M sold.
- 134 institutional investors held DermTech, Inc. Common Stock (DMTK) as of Q2 2022, down from 152 in Q1 2022.
- Funds reported $97.7M of DermTech, Inc. Common Stock stock for Q2 2022, down 71% quarter-over-quarter.
- 27 funds opened new DermTech, Inc. Common Stock positions in Q2 2022 and 42 closed out, a net change of -15 holders.
- The largest DermTech, Inc. Common Stock buyer in Q2 2022 was UBS O'Connor, an estimated $13.6M added.
- The largest DermTech, Inc. Common Stock seller in Q2 2022 was Casdin Capital, an estimated $25.6M sold.
Based on aggregated 13F filings for Q2 2022.